Blog: CIRS

CIRS

2024-10-29 by Djordje

Expert Doctor Unveils the Hidden Epidemic of Biotoxin/Mold Illness (CIRS)

This is an extraction from the EONutrition podcast. For more information, visit the official podcast page.

Guest: Dr Sandeep Gupta, one of the leading authorities on Mold/Biotoxin Illness & Chronic Inflammatory Response Syndrome.

A comprehensive report on diagnostic tests and treatments for Chronic Inflammatory Response Syndrome (CIRS) and mold illness based on the doctor's recommendations in the talk.

Diagnostic Tests and Treatments for CIRS (Mold Illness)

1. Key Diagnostic Tests for CIRS

  1. Vascular Endothelial Growth Factor (VEGF)

    • Purpose: VEGF is essential for blood vessel health and oxygen delivery. Low levels can indicate compromised blood flow, common in CIRS.
    • Optimal Range: This varies, but the presence of chronic inflammation and reduced VEGF could signify vascular issues related to toxin exposure.

  2. Adrenocorticotropic Hormone (ACTH) and Cortisol

    • Purpose: Measures adrenal function, as CIRS can disrupt adrenal hormones, affecting energy and stress response.
    • Key Markers: Imbalanced ACTH and cortisol levels may indicate adrenal fatigue or dysregulation due to chronic stress and inflammation.

  3. Melanocyte-Stimulating Hormone (MSH)

    • Purpose: MSH impacts immune function, gut health, and inflammation control. Low levels are commonly observed in CIRS and correlate with increased susceptibility to mold-related illness.
    • Notes: Low MSH is associated with inflammation, increased sensitivity to toxins, and immune dysregulation.

  4. Vasoactive Intestinal Polypeptide (VIP)

    • Purpose: VIP regulates inflammation and immune response. Low VIP levels are typical in CIRS and contribute to symptoms like fatigue, pain, and brain fog.
    • Notes: VIP nasal spray may be prescribed as part of treatment if levels are low, although this is generally done later in treatment to avoid worsening inflammation.

  5. Transforming Growth Factor Beta-1 (TGF-b1)

    • Purpose: TGF-b1 is a key marker of immune system activation and tissue inflammation.
    • Optimal Range: 867 - 6,662 pg/mL. Elevated TGF-b1 indicates an immune response to chronic inflammation, often linked with mold exposure.
    • Notes: High levels are managed through anti-inflammatory treatments and binders to reduce systemic biotoxin load.

  6. Matrix Metalloproteinase-9 (MMP-9)

    • Purpose: MMP-9 is an enzyme related to inflammatory response, especially in blood vessels. Elevated levels are common in CIRS and can indicate increased vascular permeability.
    • Notes: MMP-9 levels are controlled by anti-inflammatory agents and lifestyle adjustments to reduce inflammation.

  7. Complement C4a and C3a Proteins

    • Purpose: These proteins are markers for immune response and inflammation. Elevated levels indicate immune activation in response to biotoxins.
    • Notes: High C4a levels specifically correlate with exposure to water-damaged buildings, and managing this requires addressing environmental sources of exposure.

  8. NeuroQuant MRI (Optional)

    • Purpose: Measures structural brain changes that occur in response to chronic inflammation, often present in CIRS.
    • Key Areas: White matter inflammation or atrophy in specific brain regions can indicate the neurological impact of mold toxicity.

2. Treatment Protocols for CIRS

A. Toxin Binding Agents

  1. Cholestyramine

    • Usage: A primary binder used to sequester and remove biotoxins from the body.
    • Dosage: Often prescribed in powder form, taken multiple times per day. Exact dosage is patient-specific.
    • Notes: Ensure regular bowel movements to avoid toxin reabsorption, and separate intake from other medications/supplements.

  2. Activated Charcoal, Bentonite Clay, and Zeolite

    • Usage: Additional binders, particularly for patients sensitive to Cholestyramine.
    • Notes: These help reduce toxin levels and should be used with adequate hydration and bowel regulation.

  3. Modified Citrus Pectin

    • Usage: Primarily for chemical toxicity but also considered for its binding properties in toxin removal.
    • Notes: Generally reserved for those with chemical sensitivities rather than as a primary mold binder.

B. Anti-Inflammatory and Immune-Modulating Therapies

  1. VIP (Vasoactive Intestinal Peptide) Nasal Spray

    • Usage: Administered in cases with low VIP levels to reduce inflammation and improve immune regulation.
    • Timing: Typically introduced later in treatment once inflammation is managed to avoid aggravating symptoms.

  2. Omega-3 Fatty Acids and Curcumin

    • Usage: Anti-inflammatory supplements to help reduce systemic inflammation and support recovery.
    • Notes: Often used alongside binders and other therapies for comprehensive support.

C. Hormonal and Methylation Support

  1. SAMe (S-Adenosyl Methionine)

    • Usage: For patients with undermethylation issues, SAMe supports detox pathways and improves neurological function.
    • Notes: Patients with the COMT gene mutation should use SAMe cautiously, as it can cause overstimulation.

  2. Hydroxocobalamin and Folate

    • Usage: These support methylation and help regulate inflammation. Folate can decrease overmethylation for those with sensitivities.

D. Antimicrobial and Immune-Supporting Agents

  1. CellCore Biosciences Products
    • Usage: Products such as “Para” series for parasite cleansing and “BioToxin Binder” with fulvic acid for toxin binding.
    • Notes: Often included in detox protocols, but should be used cautiously to avoid overwhelming the system.

3. Monitoring and Lifestyle Recommendations

  • Home Environment Testing: Use HERSTMI-2 or EMMA tests to detect mold presence and assess toxin exposure in living spaces. Ensuring a safe, mold-free environment is essential for treatment success.
  • Genetic Testing: Identifies vulnerabilities like the HLA-DR gene, which may make individuals more susceptible to mold illness.
  • Hydration and Bowel Health: Maintaining adequate hydration and digestive regularity is critical during detox to facilitate toxin elimination and prevent reabsorption.
  • Professional Guidance: A qualified practitioner should oversee testing and treatment, as protocols are highly individualized and should be tailored to personal needs and test results.

This report combines all the diagnostics, treatments, and specific considerations discussed by the doctor for effectively managing CIRS and mold illness. Each component works to address biotoxin burden, immune dysregulation, and inflammation, contributing to an integrated approach to recovery.